NCT03112057

Brief Summary

The purpose of this experiment is to establish a solid medical foundation for the successful development of non-invasive harmonic generation (HGM) microscopic slicing methods. The purpose of this new technology platform is to directly observe the nerve endings of nociceptors To enhance understanding of how neuropathies occur, persistence, and ease. This technique will assist in the diagnosis and prognosis of patients with neuralgia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 28, 2017

Completed
16 days until next milestone

First Posted

Study publicly available on registry

April 13, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

October 1, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

October 16, 2017

Status Verified

March 1, 2017

Enrollment Period

2 months

First QC Date

March 28, 2017

Last Update Submit

October 12, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • nerve ending number measurement

    Use of harmonic generation (HGM) microscopic virtual biopsy methods to obtain 3D live images.

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • nerve ending structure measurement

    through study completion, an average of 1 year

Study Arms (5)

Healthy subjects

EXPERIMENTAL

Healthy subjects of different ages (20 persons), Interventions: harmonic generation microscopy

Diagnostic Test: harmonic generation (HGM) microscopic methods.

peripheral neuropathy

EXPERIMENTAL

the participant have symptoms and diagnosed with peripheral neuropathy (90 persons), Interventions:harmonic generation microscopy

Diagnostic Test: harmonic generation (HGM) microscopic methods.

diabetic neuropathy

EXPERIMENTAL

the participant have symptoms and diagnosed with diabetic neuropathy (20 persons), Interventions:harmonic generation microscopy

Diagnostic Test: harmonic generation (HGM) microscopic methods.

chemotherapy induced neuropathy

EXPERIMENTAL

before chemotherapy, during chemotherapy, after peripheral nerve lesions were cured (30 persons). Interventions:harmonic generation microscopy

Diagnostic Test: harmonic generation (HGM) microscopic methods.

Polydactyly

EXPERIMENTAL

Abandoned extra digit specimen of polydactyly(10 persons): the normal skin and nerve endings in extra digit: Interventions: harmonic generation microscopy

Diagnostic Test: harmonic generation (HGM) microscopic methods.

Interventions

a frequency-dependent optical microscopy system with a near-infrared light source with a wavelength of 1230 nm was used to detect the diseased site and normal skin.Use erbium-Jacob (Er-YAG) laser exfoliation. the participants need to lie down, wear goggles. The lens sucker device to help fix the skin examination site. Based on the experience of the past 118 subjects, the participants did not discomfort. The total time of the laser irradiation on the same skin is no more than 30 minutes, the maximum laser power is no more than 0.15 watts, irradiation in the skin of the total energy of the laser does not exceed 270 joules. After the experiment, the investigators immediately check the skin for the participants

Healthy subjectsPolydactylychemotherapy induced neuropathydiabetic neuropathyperipheral neuropathy

Eligibility Criteria

Age20 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy subjects of different ages
  • abandoned extra digit specimen in polydactyly
  • diagnosed with peripheral neuropathy
  • diabetic neuropathy patients have been removed after the completion of clinical diagnosis of the specimen, And then the skin slices of the nerve endings of the optical image observation
  • because of chemotherapy during chemotherapy, is expected to have peripheral neuropathy: before the occurrence of peripheral neuropathy , after cured peripheral nerve lesions

You may not qualify if:

  • systemic infection or have been infected with the site by the physician assessment is not suitable for examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

MeSH Terms

Conditions

Peripheral Nervous System Diseases

Condition Hierarchy (Ancestors)

Neuromuscular DiseasesNervous System Diseases

Central Study Contacts

LIN Wen-ying, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2017

First Posted

April 13, 2017

Study Start

October 1, 2017

Primary Completion

December 1, 2017

Study Completion

December 1, 2021

Last Updated

October 16, 2017

Record last verified: 2017-03

Locations